POLO pathway discovery by UBC and U of T
Analysis based on 6 articles · First reported Jul 17, 2026 · Last updated Jul 23, 2026
The discovery is foundational but early-stage, with no immediate market impact. Long-term, it could open new avenues for drug development and treatment of eye diseases, potentially benefiting pharmaceutical and biotechnology companies focused on ophthalmology.
Researchers from the University of British Columbia and the University of Toronto have discovered a previously unknown waste drainage system at the back of the eye, called the posterior ocular lymphatic outflow (POLO) pathway. This pathway provides a route for fluid and waste to exit the eye and enter the body's lymphatic system. The discovery challenges a century-old belief that the eye lacks a lymphatic system and could fundamentally shift understanding and treatment of leading causes of blindness such as glaucoma and age-related macular degeneration. The study was published in Translational Vision Science & Technology and supported by several funding agencies including the Canada — Canadian Institutes of Health Research, Glaucoma Research Society of Canada, Canada — Canadian Space Agency, and Canada Foundation for Innovation. Further research is needed to confirm the pathway in humans and develop potential therapies.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard